EBRO 2017

Trials of radiotherapy after mastectomy and axillary dissection

1314 pN1-3 women

RT: Significant benefit

Locoregional recurrence first

Any first recurrence Breast cancer mortality

11.5%

7.9 %

Years since randomisation Years since randomisation

Years since randomisation

EBCTCG, Lancet 2014